C
리센스메디컬
394420KOSDAQ의료용 기기 제조업49.3 / 100
Reference Date: 2026-06-10
Financial Score16.0 / 40
News Sentiment21.3 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk. Plunged 43.2% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
License Medical develops innovative medical devices through the FDA De Novo process and specializes in regulatory evaluation for retinal and diagnostic medical devices. The company leverages cryogenic cooling technology and transdermal drug delivery systems to create advanced solutions for ophthalmic conditions such as macular degeneration and diabetic retinopathy.
Number of Employees
55people
Average Salary
54.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 21.514.0Point
PBR
—Industry Average 1.383.5Point
ROE
—Industry Average 8.003.5Point
Debt Ratio
27.41Industry Average 11.650.0Point
2.4x industry avg (risky)
Trend 5.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
2.0 / 4
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85
- Positive‘상상상상’ 778% 폭등…요즘 뜨거운 로봇 새내기주 정체는
리센스메디컬의 상장 첫날 급등은 높은 상승률과 FDA 인증 및 미국 시장 진출 기대감으로 인한 긍정적 반응.
Detailed Momentum
52-week position1.0Point
Near 52w low (5%, downtrend)
Current 19,250Won52-week high 33,90052-week low 18,450
1-month return0.0Point
1m -43.22% (strong drop)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
3 totalPositive 0Neutral 3Negative 0
- Neutral주식등의대량보유상황보고서(약식)2026-06-09
- Neutral[기재정정]주식등의대량보유상황보고서(일반)2026-05-22
- Neutral분기보고서 (2026.03)2026-05-15